Skip to main content
. Author manuscript; available in PMC: 2010 Sep 1.
Published in final edited form as: Pediatr Blood Cancer. 2009 Sep;53(3):432–437. doi: 10.1002/pbc.22082

TABLE IV.

Risk of thyroid cancer among 5-year acute lymphoblastic leukemia survivors without prior relapse, hematopoietic cell transplant, thyroidectomy, or other secondary malignancies.

Observed Expected* SIR 95% CI
All survivors 13 2.7 4.8 (2.6, 8.2)
 Chemotherapy only 0 0.7 0 (0, 5.1)
 Cranial radiotherapy only 3 1.7 1.8 (0.4, 5.3)
 Craniospinal radiotherapy 10 0.3 30.3 (14.5, 55.7)

SIR, standardized incidence ratio;

*

based on age and sex-specific SEER incidence data.